Hester Biosciences Balance Sheet Health
Financial Health criteria checks 2/6
Hester Biosciences has a total shareholder equity of ₹3.0B and total debt of ₹2.4B, which brings its debt-to-equity ratio to 78.9%. Its total assets and total liabilities are ₹6.6B and ₹3.6B respectively. Hester Biosciences's EBIT is ₹471.2M making its interest coverage ratio 2.4. It has cash and short-term investments of ₹153.0M.
Key information
78.9%
Debt to equity ratio
₹2.39b
Debt
| Interest coverage ratio | 2.4x |
| Cash | ₹153.04m |
| Equity | ₹3.03b |
| Total liabilities | ₹3.59b |
| Total assets | ₹6.62b |
Recent financial health updates
These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Nov 25
These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Aug 25
Recent updates
Revenues Working Against Hester Biosciences Limited's (NSE:HESTERBIO) Share Price
Jun 12Hester Biosciences (NSE:HESTERBIO) Has Announced A Dividend Of ₹10.00
Aug 01Would Hester Biosciences Limited (NSE:HESTERBIO) Be Valuable To Income Investors?
Mar 03Did You Miss Hester Biosciences' (NSE:HESTERBIO) Whopping 308% Share Price Gain?
Feb 13What Is The Ownership Structure Like For Hester Biosciences Limited (NSE:HESTERBIO)?
Jan 26Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Jan 11Hester Biosciences Limited's (NSE:HESTERBIO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 25Are Hester Biosciences's (NSE:HESTERBIO) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 10These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Nov 25How Does Hester Biosciences Limited (NSE:HESTERBIO) Fare As A Dividend Stock?
Nov 10If You Had Bought Hester Biosciences (NSE:HESTERBIO) Shares Five Years Ago You'd Have Earned 212% Returns
Oct 26What Type Of Shareholders Own The Most Number of Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Oct 05Are Strong Financial Prospects The Force That Is Driving The Momentum In Hester Biosciences Limited's NSE:HESTERBIO) Stock?
Sep 14These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Aug 25How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?
Aug 07Hester Biosciences Limited (NSE:HESTERBIO) Is Yielding 0.5% - But Is It A Buy?
Jul 07Financial Position Analysis
Short Term Liabilities: HESTERBIO's short term assets (₹2.1B) exceed its short term liabilities (₹1.1B).
Long Term Liabilities: HESTERBIO's short term assets (₹2.1B) do not cover its long term liabilities (₹2.5B).
Debt to Equity History and Analysis
Debt Level: HESTERBIO's net debt to equity ratio (73.9%) is considered high.
Reducing Debt: HESTERBIO's debt to equity ratio has increased from 49.4% to 78.9% over the past 5 years.
Debt Coverage: HESTERBIO's debt is well covered by operating cash flow (20.1%).
Interest Coverage: HESTERBIO's interest payments on its debt are not well covered by EBIT (2.4x coverage).